EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Nanomedicine-Enhanced CAR-Engineered Immunotherapy for Lung Cancer: Focusing on Multimodal Strategies and Precision Therapy

Xianye He, Jiao He, Zhongsong Zhang, Yuanyin Teng iD, Bing Wang, Hao Sun iD, Xiang Deng iD, Junjun Xiong, Yuzhuo Huang

International Journal of Nanomedicine · 2026-11 · Volume 21 · 1-60

DOI: 10.2147/ijn.s651751 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026-11. Verfasst von Xianye He und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Luzhou Maternal & Child Health Hospital, Luzhou Second People's Hospital, Luzhou Women and Children's Hospital, L…. Hauptthemen laut MEDLINE: Lung Neoplasms, Receptors, Chimeric Antigen, Nanomedicine, Immunotherapy, Adoptive. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsReceptors, Chimeric AntigenNanomedicineImmunotherapy, AdoptiveHumansPrecision MedicineAnimalsImmunotherapyCombined Modality TherapyTumor Microenvironment

Stichwörter der Autor:innen

CAR-T cell therapyin situ CAR programminglung cancernanomedicineprecision immunotherapypulmonary delivery

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Luzhou Maternal & Child Health Hospital, Luzhou Second People's Hospital, Luzhou Women and Children's Hospital, Luzhou, Sichuan, 646000, People's Republic of China.
  • Department of Health Management Center, Luzhou Maternal & Child Health Hospital, Luzhou Second People's Hospital, Luzhou Women and Children's Hospital, Luzhou, Sichuan, 646000, People's Republic of China.
  • School of Clinical Medicine, Chengdu Medical College, Chengdu, Sichuan, 610500, People's Republic of China.
  • Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, 310003, People's Republic of China.
  • Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.
  • Wolfson Institute for Biomedical Research, UCL Division of Medicine, University College London, London, WC1E 6BT, UK.

ORCID-Profile: Yuanyin Teng, Hao Sun, Xiang Deng

Zitieren

APA

He, X., He, J., Zhang, Z., Teng, Y., Wang, B., Sun, H., Deng, X., Xiong, J., & Huang, Y. (2026). Nanomedicine-Enhanced CAR-Engineered Immunotherapy for Lung Cancer: Focusing on Multimodal Strategies and Precision Therapy. International Journal of Nanomedicine, Volume 21, 1-60. https://doi.org/10.2147/ijn.s651751

Vancouver

He X, He J, Zhang Z, Teng Y, Wang B, Sun H, et al. Nanomedicine-Enhanced CAR-Engineered Immunotherapy for Lung Cancer: Focusing on Multimodal Strategies and Precision Therapy. International Journal of Nanomedicine. 2026;Volume 21:1-60. doi:10.2147/ijn.s651751

BibTeX
@article{He2026,
  author = {He, Xianye and He, Jiao and Zhang, Zhongsong and Teng, Yuanyin and Wang, Bing and Sun, Hao and Deng, Xiang and Xiong, Junjun and Huang, Yuzhuo},
  title = {Nanomedicine-Enhanced CAR-Engineered Immunotherapy for Lung Cancer: Focusing on Multimodal Strategies and Precision Therapy},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  volume = {Volume 21},
  pages = {1--60},
  doi = {10.2147/ijn.s651751}
}
Kostenlos starten →